# OnCo record paper-ricciuti-tmb-pd-l1-levels-jama-oncol-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: .
@prefix onco: .
@prefix xsd: .
a schema:ScholarlyArticle ;
onco:kind "paper" ;
schema:identifier "paper-ricciuti-tmb-pd-l1-levels-jama-oncol-2022" ;
schema:name "Association of high tumor mutation burden in non-small cell lung cancers with increased immune infiltration and improved clinical outcomes of PD-L1 blockade across PD-L1 expression levels"@en ;
schema:description "Pooling more than fifteen hundred patients showed that the more mutations a lung cancer carries the better immunotherapy works, at every level of the PD-L1 stain, but the best dividing line was about twice the number the licensing authorities use."@en ;
schema:url ;
schema:dateModified "2026-09-25"^^xsd:date ;
schema:citation , ;
schema:sameAs ;
schema:datePublished "2022"^^xsd:gYear ;
schema:author "Ricciuti B, Wang X, Alessi JV, et al." ;
onco:related , ;
onco:cancers ;
onco:technologies , , , ;
onco:targets , ;
onco:institutions , ;
onco:pathways , ;
onco:terms , , ;
onco:people ;
onco:journals .